The promoter region of the E-cadherin gene is methylated in high-grade prostate tumors and cell lines, and treatment with the DNMT1-targeting decitabine restored E-cadherin mRNA expression in prostate cancer cell lines [28]. The gene discussed is DNMT1; the disease is prostate neoplasm.